Status:
COMPLETED
Study in Patients With Asthma
Lead Sponsor:
Dey
Conditions:
Asthma
Eligibility:
All Genders
5-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.
Eligibility Criteria
Inclusion
- Patients with a history of asthma
Exclusion
- Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization
- History of smoking
- Debilitating systemic and/or life-threatening diseases.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00215397
End Date
December 1 2005
Last Update
November 11 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Long Beach, California, United States, 90806
2
Research Site
Denver, Colorado, United States, 80206
3
Research Site
Medford, Oregon, United States, 97504